Der er ialt evalueret 2. 182 patienter i kliniske forsøg; af disse var 25% ≥ 65 år og 5% ≥ 75 år.
A total of 2,182 patients were evaluated in clinical trials; of these 25% were ≥ 65 years of age and 5% were ≥ 75 years of age.